Irinotecan Liposome Clinical Trials
4 recruitingDrug
Not Applicable1Phase 11Phase 21
Showing 1–4 of 4 trials
Recruiting
Not Applicable
Irinotecan Liposome Combined With Anlotinib as Second-line Regimen for SCLC
Small Cell Lung Cancer Recurrent
Fudan University39 enrolled1 locationNCT06258642
Recruiting
Phase 2
Phase II Study of Irinotecan Liposomes in First-line Treatment of Metastatic Colorectal Cancer
Metastatic Colorectal Cancer
West China Hospital86 enrolled1 locationNCT06341296
Recruiting
Real-world Study to Evaluate the Efficacy and Safety of Liposome Irinotecan
Peking University933 enrolled1 locationNCT06443307
Recruiting
Phase 1
Dose Escalation and Expansion Clinical Trial of Irinotecan Liposome Combined With Oxaliplatin and 5-FU/LV Plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer
Metastatic Colorectal Cancer
Shanghai Zhongshan Hospital78 enrolled1 locationNCT06225622